Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections
- 1 April 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 74 (4) , 694-699
- https://doi.org/10.1016/0002-9343(83)91029-x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Moxalactam therapy for a wide spectrum of bacterial infections in adultsAntimicrobial Agents and Chemotherapy, 1981
- Clinical Efficacy of Moxalactam with Emphasis on Infections Due to Multidrug-Resistant Organisms in Patients with Renal InsufficiencyChemotherapy, 1981
- Moxalactam (6059-S), a Novel 1-Oxa-β-Lactam with an Expanded Antibacterial Spectrum: Laboratory EvaluationAntimicrobial Agents and Chemotherapy, 1980
- Pharmacology of a New 1-Oxa-β-lactam (LY127935) in Normal VolunteersAntimicrobial Agents and Chemotherapy, 1980
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- A Randomized, Comparative Study of Tobramycin and Gentamicin in Treatment of Acute Urinary Tract InfectionsThe Journal of Infectious Diseases, 1976
- Comparison of Tobramycin and Gentamicin in the Treatment of Complicated Urinary Tract InfectionsThe Journal of Infectious Diseases, 1976
- Serum versus Urinary Antimicrobial Concentrations in Cure of Urinary-Tract InfectionsNew England Journal of Medicine, 1974
- TobramycinThe Lancet Healthy Longevity, 1973
- The Pathogenesis of Experimental Enterococcal Pyelonephritis in MiceThe Journal of Infectious Diseases, 1961